Bullish Case: IMAX's asset-light premium-format moat is compounding: The Odyssey became the first film to gross $500M on IMAX screens, Dune: Part Three's Dec 18 IMAX 70mm demand crashed ticketing sites, and Narnia (Feb 2027, IMAX previews Feb 10) extends the 2027 corridor. Helium's density maps a $50-55 node with a secondary $55-60 node, calls outtrade puts 58%, and Helium's AI forecast is +5.28% (though realized correlation is -0.1, so weight modestly). Street targets sit at $55-61.

Bearish Case: At $50.86, IMAX is near record highs after a 57.8% one-year run with good news priced. Disney's Infinity Vision (5,500 qualifying auditoriums vs IMAX's network) is recruiting rival studios and took Doomsday's December slot away from IMAX—direct format-competition risk. Term structure is backwardated, deep-OTM put wings carry 90-177% IVs, and SPY's surface shows fat downside skew; a macro drawdown or faded premium demand pulls shares toward the $45-50 Helium mass.

Potential Outcomes:

1. Dune: Part Three blowout (Dec 18), sellouts + record IMAX grosses: $55-62 within 60-90d — 30%.
2. In-line slate + Q3 print, Everest and Godzilla Minus Zero steady: $50-56 consolidation — 30%.
3. Format-competition erosion: Infinity Vision wins studio commitments, Doomsday Dolby presales outshine IMAX exclusivity: drift to $45-50 — 22%.
4. Macro/SPY shock with backwardated IV and put-skew spillover: <$44 — 8%.
5. Q3 earnings miss or dilution/convert headline (late-Oct/early-Nov report): -8-12% — 7%.
6. M&A headline either direction: gap move — 3%.

Weights reflect Helium's price density concentrated at $50 with an upper node at $55-60, treated as scenario weights, not frequencies.

October 17, 2026